219 related articles for article (PubMed ID: 27884650)
41. Bleeding complications associated with anticoagulant therapy in patients with cancer.
Trujillo-Santos J; Nieto JA; Ruíz-Gamietea A; López-Jiménez L; García-Bragado F; Quintavalla R; Monreal M;
Thromb Res; 2010 Apr; 125 Suppl 2():S58-61. PubMed ID: 20434007
[TBL] [Abstract][Full Text] [Related]
42. Anticoagulant use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Rahme E; Feugère G; Sirois C; Weicker S; Ramos E
Thromb Res; 2013 Mar; 131(3):210-7. PubMed ID: 23290095
[TBL] [Abstract][Full Text] [Related]
43. Outcome during and after anticoagulant therapy in cancer patients with incidentally found pulmonary embolism.
Peris M; Jiménez D; Maestre A; Font C; Tafur AJ; Mazzolai L; Xifre B; Skride A; Dentali F; Monreal M;
Eur Respir J; 2016 Nov; 48(5):1360-1368. PubMed ID: 27660517
[TBL] [Abstract][Full Text] [Related]
44. Long-term therapy with low-molecular-weight heparin in cancer patients with venous thromboembolism.
Marchena PJ; Nieto JA; Guil M; García-Bragado F; Rabuñal R; Boccalon H; Trujillo-Santos J; Monreal M;
Thromb Haemost; 2012 Jan; 107(1):37-43. PubMed ID: 22116496
[TBL] [Abstract][Full Text] [Related]
45. Clinical Outcomes of Venous Thromboembolism in Patients with and without Cancer: The SWIss Venous ThromboEmbolism Registry (SWIVTER).
Spirk D; Aujesky D; Stuck AK; Beer JH; Mazzolai L; Baldi T; Banyai M; Hayoz D; Kaeslin T; Korte W; Escher R; Husmann M; Frauchiger B; Baumgartner I; Kucher N
Semin Thromb Hemost; 2016 Sep; 42(6):642-9. PubMed ID: 27272967
[TBL] [Abstract][Full Text] [Related]
46. Venous thromboembolism in immobilized patients with dementia. Findings from the RIETE registry.
Nuñez MJ; Villalba JC; Cebrián E; Visoná A; Lopez-Jimenez L; Núñez M; Szwebel TA; Luque JM; Jaras MJ; Monreal M;
Thromb Res; 2012 Aug; 130(2):173-7. PubMed ID: 22374336
[TBL] [Abstract][Full Text] [Related]
47. Influence of primary cancer site on clinical outcomes of anticoagulation for associated venous thromboembolism.
Wysokinski WE; Houghton DE; Vlazny DT; Ashrani AA; Froehling DA; Kamath PS; Meverden RA; Hodge DO; Peterson LG; Lang TR; McBane RD; Casanegra AI
Thromb Res; 2023 Jan; 221():37-44. PubMed ID: 36463701
[TBL] [Abstract][Full Text] [Related]
48. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
49. Influence of recent immobilization or surgery on mortality in cancer patients with venous thromboembolism.
Trujillo-Santos J; Gussoni G; Gadelha T; Sänchez Muñoz-Torrero JF; Barron M; Lopez L; Ruiz-Ruiz J; Fernandez-Capitan C; Lorente M; Monreal M;
Thromb Res; 2014 May; 133 Suppl 2():S29-34. PubMed ID: 24862142
[TBL] [Abstract][Full Text] [Related]
50. Rationale, design and methodology of TESEO study: a registry of thrombosis and neoplasia of SEOM (Spanish Society of Medical Oncology).
Muñoz-Langa J; Jimenez-Fonseca P; Carmona-Bayonas A; de Castro EM; Pérez-Segura P; Cánovas MS; Gomez D; Moran LO; de Tejada MBG; Seguí E; López GB; Adrián SG; Campos MC; Olmos VP; Portero BO; Moyano MS; Crespo JAS; Sánchez LT; Rebollo MA; Rivas PO; Altozano JP; Lescure ÁR; Muñoz-Martín A
Clin Transl Oncol; 2021 Apr; 23(4):799-811. PubMed ID: 32789772
[TBL] [Abstract][Full Text] [Related]
51. Long-Term Anticoagulant Therapy of Patients with Venous Thromboembolism. What Are the Practices?
Mahé I; Sterpu R; Bertoletti L; López-Jiménez L; Mellado Joan M; Trujillo-Santos J; Ballaz A; Hernández Blasco LM; Marchena PJ; Monreal M;
PLoS One; 2015; 10(6):e0128741. PubMed ID: 26076483
[TBL] [Abstract][Full Text] [Related]
52. Survival effects of inferior vena cava filter in patients with acute symptomatic venous thromboembolism and a significant bleeding risk.
Muriel A; Jiménez D; Aujesky D; Bertoletti L; Decousus H; Laporte S; Mismetti P; Muñoz FJ; Yusen R; Monreal M;
J Am Coll Cardiol; 2014 Apr; 63(16):1675-83. PubMed ID: 24576432
[TBL] [Abstract][Full Text] [Related]
53. Clinical outcomes of a pharmacist-managed anticoagulation service for breast cancer patients.
Jones KL; Barnett C; Gauthier M; Boster B; Espirito JL; Michaud LB
J Oncol Pharm Pract; 2012 Mar; 18(1):122-7. PubMed ID: 21364079
[TBL] [Abstract][Full Text] [Related]
54. Duration of anticoagulation therapy for venous thromboembolism.
Bounameaux H; Perrier A
Hematology Am Soc Hematol Educ Program; 2008; ():252-8. PubMed ID: 19074092
[TBL] [Abstract][Full Text] [Related]
55. Treatment of venous thromboembolism in ambulatory cancer patients in Germany: a prospective non-interventional study.
Matzdorff A; Schilling H; Ledig B
Oncol Res Treat; 2015; 38(4):174-80. PubMed ID: 25877941
[TBL] [Abstract][Full Text] [Related]
56. Tinzaparin and VKA use in patients with cancer associated venous thromboembolism: a retrospective cohort study.
Noel-Savina E; Sanchez O; Descourt R; André M; Leroyer C; Meyer G; Couturaud F
Thromb Res; 2015 Jan; 135(1):78-83. PubMed ID: 25466839
[TBL] [Abstract][Full Text] [Related]
57. Unsuspected pulmonary embolism in patients with cancer.
Soler S; Delgado C; Ballaz A; Cisneros E; Malý R; Babalis D; Monréal M;
Thromb Res; 2012 Apr; 129 Suppl 1():S16-9. PubMed ID: 22682127
[TBL] [Abstract][Full Text] [Related]
58. [Optimal duration of anticoagulation of venous thromboembolism].
Savina EN; Couturaud F
J Mal Vasc; 2011 Dec; 36 Suppl 1():S28-32. PubMed ID: 22177766
[TBL] [Abstract][Full Text] [Related]
59. Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients.
Delluc A; Le Gal G; Scarvelis D; Carrier M
Thromb Res; 2015 Feb; 135(2):298-302. PubMed ID: 25491940
[TBL] [Abstract][Full Text] [Related]
60. Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: a comparison with symptomatic patients.
den Exter PL; Hooijer J; Dekkers OM; Huisman MV
J Clin Oncol; 2011 Jun; 29(17):2405-9. PubMed ID: 21555690
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
